FIELD: medicine.
SUBSTANCE: invention refers to treatment and/or prevention of skin toxicity caused by a targeted therapy. Method comprises administering to patient a pharmaceutical composition for local application containing 0.1 to 0.3 wt % berberine, and said targeted therapy is selected from a group consisting of MEK inhibitors, HER2 inhibitors and mTOR inhibitors.
EFFECT: invention provides a wider range of products, namely new effective methods of treating various skin diseases, accompanied by face redness, as well as skin toxicity caused by the targeted therapy.
6 cl, 2 tbl, 4 ex, 7 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREPARING WATER-SOLUBLE PHARMACEUTICAL COMPOSITION BASED ON BERBERINE | 2023 |
|
RU2814497C1 |
| COMPOSITIONS CONTAINING BERBERINE OR ANALOGS THEREOF FOR TREATING ROSACEA OR RED FACE RELATED SKIN DISORDERS | 2014 |
|
RU2671492C2 |
| COMPOSITIONS CONTAINING BERBERINE OR ITS ANALOGUES FOR TREATING SKIN DISEASES RELATED TO ROSACEA OR BLUSH | 2010 |
|
RU2533458C2 |
| METHOD OF TREATING PALMAR-PLANTAR ERYTHRODYSESTHESIA | 2018 |
|
RU2722396C2 |
| COMPOSITION OF DERMAL MEDICATION FOR EXTERNAL APPLICATION | 2010 |
|
RU2572694C2 |
| METHOD FOR TREATING DISEASES AND CONDITIONS OF THE EYE | 2012 |
|
RU2667645C1 |
| METHOD OF RADIOINDUCED SKIN REACTIONS TREATMENT | 2022 |
|
RU2796754C1 |
| PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF SKIN DISEASES AND CONDITIONS CONTAINING 7-(1H-IMIDAZOL-4-YLMETHYL)-5,6,7,8-TETRAHYDROQUINOLINE | 2012 |
|
RU2630978C2 |
| METHOD FOR TREATMENT OF COMPLICATIONS OF CONTOUR PLASTIC SURGERY | 2020 |
|
RU2747423C1 |
| TRAILING MAHONIA EXTRACT, PRODUCTION METHOD AND PHARMACEUTICAL COMPOSITION CONTAINING EXTRACT | 2004 |
|
RU2388482C2 |
